Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.74)
# 2,789
Out of 4,579 analysts
102
Total ratings
36.5%
Success rate
2.8%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AIM: AMS Advanced Medical Solutions Group plc | Maintained: Buy | 245p | 281p | -12.66% | 12 | May 21, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | 220p | +43.05% | 10 | Mar 11, 2026 | |
| PLLWF Polarean Imaging plc | Maintained: Buy | $0.11 → $0.05 | $0.0066 | +705.58% | 9 | Sep 25, 2025 | |
| AIM: DXRX Diaceutics PLC | Maintained: Buy | 225p | 128p | +75.78% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Maintained: Buy | 29p → 35p | 26p | +37.25% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Maintained: Hold | 1,850p → 2,300p | 2,220p | +3.60% | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | 1,577p | n/a | 8 | Apr 24, 2025 | |
| INDV Indivior Pharmaceuticals | Maintained: Buy | $15 | $40.03 | n/a | 4 | Apr 24, 2025 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | 394p → 406p | 383p | n/a | 5 | Mar 21, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Reiterated: Buy | €4.00 | €0.83 | n/a | 3 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.13 | n/a | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 105p | 69p | n/a | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €109.00 | €80.00 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €231.24 → €249.71 | €26.00 | n/a | 9 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,514p → 4,138p | 5p | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 7,147p → 5,642p | 55p | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,648p → 14,144p | 66p | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 13,166p | 0.12p | n/a | 3 | May 18, 2017 |
Advanced Medical Solutions Group plc
May 21, 2026
Maintained: Buy
Price Target: 245p
Current: 281p
Upside: -12.66%
Convatec Group PLC
Mar 11, 2026
Reiterated: Buy
Price Target: 315p
Current: 220p
Upside: +43.05%
Polarean Imaging plc
Sep 25, 2025
Maintained: Buy
Price Target: $0.11 → $0.05
Current: $0.0066
Upside: +705.58%
Diaceutics PLC
Sep 23, 2025
Maintained: Buy
Price Target: 225p
Current: 128p
Upside: +75.78%
EKF Diagnostics Holdings plc
Sep 16, 2025
Maintained: Buy
Price Target: 29p → 35p
Current: 26p
Upside: +37.25%
Genus plc
Sep 9, 2025
Maintained: Hold
Price Target: 1,850p → 2,300p
Current: 2,220p
Upside: +3.60%
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: 1,577p
Upside: n/a
Indivior Pharmaceuticals
Apr 24, 2025
Maintained: Buy
Price Target: $15
Current: $40.03
Upside: n/a
Uniphar plc
Mar 21, 2025
Reiterated: Buy
Price Target: 394p → 406p
Current: 383p
Upside: n/a
Nanoform Finland Oyj
Nov 19, 2024
Reiterated: Buy
Price Target: €4.00
Current: €0.83
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.13
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: 105p
Current: 69p
Upside: n/a
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: €80.00
Upside: n/a
Nov 12, 2018
Reiterated: Buy
Price Target: €231.24 → €249.71
Current: €26.00
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,514p → 4,138p
Current: 5p
Upside: n/a
May 24, 2018
Maintained: Buy
Price Target: 7,147p → 5,642p
Current: 55p
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,648p → 14,144p
Current: 66p
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 13,166p
Current: 0.12p
Upside: n/a